DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Japan
  • /
  • Materials
Author Program NEWCreate Narrative
4005 logo

Sumitomo Chemical Company, Limited Stock Price

TSE:4005 Community·JP¥939.6b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

4005 Share Price Performance

JP¥0
-484.10 (-100.00%)
​
JP¥655.70
Fair Value
JP¥0
-484.10 (-100.00%)
​
Price JP¥0
Fri, 3 Jul 26
Fair ValueJP¥655.70
Share Pricen/a

4005 Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value JP¥655.7 15.0% undervalued intrinsic discount

Earnings Outlook And Discount Rate Adjustments Will Shape Market Direction

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value JP¥848.33 34.3% undervalued intrinsic discount

Digitization And Green Shifts Will Fuel Material And Crop Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value JP¥500 11.5% overvalued intrinsic discount

Legacy Petrochemical Divisions Will Face Escalating Compliance Costs

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
4005 logo
Sumitomo Chemical Company
34.3% undervalued intrinsic discount

Digitization And Green Shifts Will Fuel Material And Crop Markets

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 31 Jul
Read Narrative
4005 logo
Sumitomo Chemical Company
15.0% undervalued intrinsic discount

Earnings Outlook And Discount Rate Adjustments Will Shape Market Direction

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 3 Jul
Read Narrative
4005 logo
Sumitomo Chemical Company
11.5% overvalued intrinsic discount

Legacy Petrochemical Divisions Will Face Escalating Compliance Costs

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 17 Jul
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystHighTarget
4005 logo

4005: Share Exchange Decision And Stronger Margins Will Support Future Upside

Fair Value: JP¥848.33 34.3% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
4005 logo

4005: Planned Share Exchange And Margin Outlook Will Shape Balanced Future Upside

Fair Value: JP¥500 11.5% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
4005 logo

4005: Lower Discount Rate And Margin Recovery Will Support Stronger Outlook

Fair Value: JP¥655.7 15.0% undervalued intrinsic discount
3 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Proven track record with adequate balance sheet and pays a dividend.

4 Risks
3 Rewards
View Full Analysis

Sumitomo Chemical Company, Limited Key Details

JP¥2.4t

Revenue

JP¥1.7t

Cost of Revenue

JP¥698.8b

Gross Profit

JP¥592.5b

Other Expenses

JP¥106.3b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
64.14
29.35%
4.46%
80.2%
View Full Analysis

About 4005

Founded
1913
Employees
27491
CEO
Nobuaki Mito
WebsiteView website
www.sumitomo-chem.co.jp

Sumitomo Chemical Company, Limited engages in Agro & Life Solutions, ICT & Mobility Solutions, Advanced Medical Solutions, Essential & Green Materials, and Sumitomo Pharma. The Agro & Life Solutions segment offers crop protection chemicals, fertilizers, agricultural materials, household insecticides, products for control of infectious diseases, and feed additives, etc. The ICT & Mobility Solutions segment provides optical products, semiconductor processing materials, compound semiconductor materials, touch screen sensor panels, high-purity aluminum and alumina, specialty chemicals, additives, engineering plastics, and battery materials, etc. The Advanced Medical Solutions segment offers contract development and manufacturing organization business for small-molecule active ingredients and intermediates, oligonucleic acid drug substances, and regenerative medicine, and cell therapy products, etc. The Essential & Green Materials segment offers synthetic resins, raw materials for synthetic fibers, various industrial chemicals, methyl methacrylate products, industrial aluminum and alumina, and synthetic rubber, etc. The Sumitomo Pharma segment offers small molecule pharmaceuticals. Additionally, the company engages in the manufacture and sale of positive electrode materials for rechargeable batteries. Sumitomo Chemical Company, Limited was founded in 1913 and is headquartered in Tokyo, Japan.

Recent 4005 News & Updates

Recent updates

No updates

Sumitomo Chemical Company, Limited Competitors

4063 logo

Shin-Etsu Chemical

Symbol: TSE:4063
Market cap: JP¥10.7t
5016 logo

JX Advanced Metals

Symbol: TSE:5016
Market cap: JP¥3.6t
5401 logo

Nippon Steel

Symbol: TSE:5401
Market cap: JP¥3.6t
4004 logo

Resonac Holdings

Symbol: TSE:4004
Market cap: JP¥3.0t
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide